The BeLOVE study is a joint interdisciplinary research project of the Berlin Institute for Health (BIH), the Max Delbrueck Center for Molecular Medicine (MDC) and the Charité – Universitätsmedizin Berlin.
At the end of July 2017 the pilot phase of the Berlin Longterm Observation of Vascular Events project (BeLOVE) was successfully launched with the recruitment of the first patient at the Clinical Research Unit (CRU) of the BIH and the clinics of the Charité. BeLOVE is an observational study aimed at understanding the relationships between cardiovascular, renal and metabolic diseases.
More information can be found here:
Back to Overview